文献速递肾移植

机器灌注与不同风险分层移植肾的长期结局

Machine perfusion and long-term kidney transplant recipient outcomes across allograft risk strata.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

总体DGF率25.4%,MP在除ECD-DCD外各亚组均降低DGF,但总体未降低DCGF;两种分类均未能识别MP长期移植物存活更优的肾。

要点

  • MP在除ECD-DCD外各亚组均显著降低DGF,总体DGF率25.4%。
  • 总体MP未降低DCGF,ECD-DBD组1–5年DCGF反而更高。
  • KDPI≤70组MP与更高的DCGF和全因移植物失败相关。

核心结论

  • 总体而言,MP未降低DCGF,且两种分类均未能更好地识别MP长期移植物存活更优的肾。
  • 作者质疑将所有移植肾广泛使用MP作为理想器官保存策略的做法。

研究设计与样本

  • 按标准/扩大标准供者(ECD)/心脏死亡后捐献(DCD)/脑死亡后捐献(DBD)分类及KDPI评分分层,各亚组内比较MP与冷储存。

主要发现

  • 总体DGF率25.4%,MP在除ECD-DCD供者亚组外的所有亚组均与显著更低的DGF相关。
  • 按供者来源分类,MP未降低DCGF,仅ECD-DCD亚组0–1年DCGF降低[aHR 0.56(95%CI 0.32–0.98)]。
  • ECD-DBD亚组1–5年DCGF更高[aHR 1.15(95%CI 1.01–1.31)]。
  • MP未降低全因移植物失败,仅ECD-DCD亚组0–1年降低[aHR 0.59(95%CI 0.38–0.91)]。
  • 按KDPI分类,MP未降低DCGF或全因移植物失败,但≤70亚组DCGF更高[aHR 1.16(95%CI 1.05–1.27)]、全因移植物失败更高[aHR 1.10(95%CI 1.02–1.18)];MP与任何亚组死亡率无关。

临床怎么用

  • MP降低DGF的效应在多数亚组可见,但不应据此预期长期移植物存活获益。
  • 对ECD-DBD及KDPI≤70的肾使用MP时,需警惕长期移植物失败风险可能升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of machine perfusion (MP) in kidney transplantation lowers delayed graft function (DGF) and improves 1-year graft survival in some, but not all, grafts. These associations have not been explored in grafts stratified by the Kidney Donor Profile index (KDPI). METHODS: We analyzed 78 207 deceased-donor recipients using the Scientific Registry of Transplant Recipients data from 2006 to 2013. The cohort was stratified using the standard criteria donor/expanded criteria donor (ECD)/donation after cardiac death (DCD)/donation after brain death (DBD) classification and the KDPI scores. In each subgroup, MP use was compared with cold storage. RESULTS: The overall DGF rate was 25.4% and MP use was associated with significantly lower DGF in all but the ECD-DCD donor subgroup. Using the donor source classification, the use of MP did not decrease death-censored graft failure (DCGF), except in the ECD-DCD subgroup from 0 to 1 year {adjusted hazard ratio [aHR] 0.56 [95% confidence interval (CI) 0.32-0.98]}. In the ECD-DBD subgroup, higher DCGF from 1 to 5 years was noted [aHR 1.15 (95% CI 1.01-1.31)]. Also, MP did not lower all-cause graft failure except in the ECD-DCD subgroup from 0 to 1 year [aHR = 0.59 (95% CI 0.38-0.91)]. Using the KDPI classification, MP did not lower DCGF or all-cause graft failure, but in the ≤70 subgroup, higher DCGF [aHR 1.16 (95% CI 1.05-1.27)] and higher all-cause graft failure [aHR 1.10 (95% CI 1.02-1.18)] was noted. Lastly, MP was not associated with mortality in any subgroup. CONCLUSIONS: Overall, MP did not lower DCGF. Neither classification better risk-stratified kidneys that have superior graft survival with MP. We question their widespread use in all allografts as an ideal approach to organ preservation.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Sandal S, Luo X, Massie AB, et al. Machine perfusion and long-term kidney transplant recipient outcomes across allograft risk strata. Nephrol Dial Transplant. 2018. PMID: 29474675. doi:10.1093/ndt/gfy010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。